Plurify Ltd
Private Limited Company · Cambridge
ActiveUnited KingdomIncorporated 2023Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-12-31
IXBRL · 127 source facts · 22 selected values
Validation findingsXBRL valid
Accounts to 2025-12-31
IXBRL · 127 source facts · 22 selected values
Validation findings
XBRL valid
- Reporting period
- 2025-01-01 to 2025-12-31
- Extraction status
- complete
- Numeric facts
- 80
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2603_15230383_20251231
- Source archive
- Accounts_Monthly_Data-March2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-12-31
IXBRL · 92 source facts · 12 selected values
Validation findingsXBRL valid
Accounts to 2024-12-31
IXBRL · 92 source facts · 12 selected values
Validation findings
XBRL valid
- Reporting period
- 2023-10-24 to 2024-12-31
- Extraction status
- complete
- Numeric facts
- 48
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2506_15230383_20241231
- Source archive
- Accounts_Monthly_Data-June2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Registered details
15230383- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2023-10-24
- Jurisdiction
- —
- Registered office
- SALISBURY HOUSE, STATION ROAD, CAMBRIDGE, CB1 2LA, ENGLAND
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
6 matched grantsFeasibility Validation for Industrial Translation of PlurifyLead
Innovate UK · Collaborative R&D · 2025-08-01 – 2026-01-31
£48,919
awarded
Building a Sustainable Platform for rAAV Gene Therapy ManufacturingLeadLiveInnovate UK · Collaborative R&D · 2025-02-01 – 2027-03-31 · with 1 other participant£347,532awarded
Building a Sustainable Platform for rAAV Gene Therapy ManufacturingLeadLive
Innovate UK · Collaborative R&D · 2025-02-01 – 2027-03-31 · with 1 other participant
£347,532
awarded
Plurify Ltdlead£347,532
Plurify: Commercial Feasibility and Derisking Industrial AdoptionLead
Innovate UK · Collaborative R&D · 2024-06-01 – 2024-11-30
£49,795
awarded
Plurify: Commercial Feasibility and Derisking Industrial AdoptionLead
TMF · Collaborative R&D · 2024-05-31 – 2024-11-30
£49,795
whole project
Plurify: Commercial Feasibility and Derisking Industrial Adoption
TMF · Collaborative R&D · 2024-05-31 – 2024-11-30
£49,795
whole project
A Flexible Molecular Platform for Agile and Scalable Cell PurificationLeadInnovate UK · Collaborative R&D · 2024-03-01 – 2025-03-31 · with 1 other participant£197,896awarded
A Flexible Molecular Platform for Agile and Scalable Cell PurificationLead
Innovate UK · Collaborative R&D · 2024-03-01 – 2025-03-31 · with 1 other participant
£197,896
awarded
Plurify Ltdlead£197,896